key: cord-0963283-zq8c41fv
authors: Kalbhenn, Johannes; Knoerlein, Julian
title: Intramuscular deposit of calcium is a potential reason for hypocalcaemia in COVID-19
date: 2021-04-08
journal: Endocrine
DOI: 10.1007/s12020-021-02708-y
sha: d129de43197d3d82845553ca5e1e3bf88b0bc0ac
doc_id: 963283
cord_uid: zq8c41fv

nan

To the Editor:

With great interest we read the letter of Singh et al. specifying several aetiologies for hypocalcaemia in coronavirus disease 19 (COVID-19) patients [1] . Hypocalcaemia is common in COVID-19 [1] and associated with decreased survical [2] . In the following by reporting the case of a patient treated with severe COVID-19 at our department we propose an additional mechanism leading to hypocalcaemia: a 44-year-old male patient with severe respiratory failure due to COVID-19 was referred to the intensive care unit for extracorporeal membrane oxygenation. On admission he presented with hypocalcaemia probably caused by the abovementioned mechanisms. During the first four weeks of therapy he needed excessive substitution of calcium-gluconate to keep serumcalcium level within the normal range ( Fig. 1) . Overall, more than 5.400 ml of calcium-gluconate 10% solution had to be infused. Computed tomography of the abdomen two weeks after referral coincidentally showed cloudy radiopaque deposits in the midst of the gluteal muscles ( Fig. 2B ) which were most likely caused by calcium. Compared to the computed tomography on admission ( Fig. 2A ) this was a new finding. We believe that precipitation of calcium in the muscle was aggravated by the excessive substitution of calcium-gluconate solution during therapy.

We found calcium precipitates also in the deltoid muscle but not in other organs. COVID-19 often is accompanied by myositis [3] . It is obvious that negatively charged valences, for example, from myoglobin are presented when muscle tissue loses its integrity and that calcium ions may accumulate and calcium salts may precipitate especially in these regions. Precipitation of calcium should be considered an additional possible reason for hypocalcaemia in COVID-19.

On request.

Author contributions J.K. and J.K. both precipitated equally in writing and editing the manuscript.

Funding Open Access funding enabled and organized by Projekt DEAL.

Conflict of interest The authors declare no competing interests.

Informed consent Legal representative of the patient gave informed consent.

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. org/licenses/by/4.0/. 

Mechanistic basis and therapeutic relevance of hypocalcemia during severe COVID-19 infection

Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients

Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy